Literature DB >> 19099060

Sculpting the beta-peptide foldamer H12 helix via a designed side-chain shape.

Anasztázia Hetényi1, Zsolt Szakonyi, István M Mándity, Eva Szolnoki, Gábor K Tóth, Tamás A Martinek, Ferenc Fülöp.   

Abstract

The long-range side-chain repulsion between the (1R,2R,3R,5R)-2-amino-6,6-dimethyl-bicyclo[3.1.1]-heptane-3-carboxylic acid (trans-ABHC) residues stabilize the H12 helix in beta-peptide oligomers.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19099060     DOI： 10.1039/b812114a

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN： 1359-7345            Impact factor:   6.222


  5 in total

1.  Crystallographic characterization of 12-helical secondary structure in β-peptides containing side chain groups.

Authors:  Soo Hyuk Choi; Ilia A Guzei; Lara C Spencer; Samuel H Gellman
Journal:  J Am Chem Soc       Date:  2010-10-06       Impact factor: 15.419

2.  Synthesis of conformationally constrained tricyclic beta-lactam enantiomers through Ugi four-center three-component reactions of a monoterpene-based beta-amino acid.

Authors:  Zsolt Szakonyi; Reijo Sillanpää; Ferenc Fülöp
Journal:  Mol Divers       Date:  2009-04-15       Impact factor: 2.943

3.  Stereoselective synthesis of perillaldehyde-based chiral β-amino acid derivatives through conjugate addition of lithium amides.

Authors:  Zsolt Szakonyi; Reijo Sillanpää; Ferenc Fülöp
Journal:  Beilstein J Org Chem       Date:  2014-11-21       Impact factor: 2.883

4.  Proteomimetic surface fragments distinguish targets by function.

Authors:  Attila Tököli; Beáta Mag; Éva Bartus; Edit Wéber; Gerda Szakonyi; Márton A Simon; Ágnes Czibula; Éva Monostori; László Nyitray; Tamás A Martinek
Journal:  Chem Sci       Date:  2020-09-10       Impact factor: 9.825

5.  Efficient regio- and stereoselective access to novel fluorinated β-aminocyclohexanecarboxylates.

Authors:  Loránd Kiss; Melinda Nonn; Reijo Sillanpää; Santos Fustero; Ferenc Fülöp
Journal:  Beilstein J Org Chem       Date:  2013-06-17       Impact factor: 2.883
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.